8 essays, spanning 2021–2022.
Dec 8, 2022
Pandemic-era signal in consumer data: what Peloton's rise and reversal reveal about subscription retention when behavior snaps back.
Jun 21, 2022
On how generative adversarial networks are outrunning the Right of Publicity — and what a new legal paradigm might look like.
Jul 11, 2021
How Walmart turned operational discipline — logistics, supplier power, technology — into a durable low-price engine.
Jun 20, 2021
Reading the Apple Newton not as a failure but as the groundwork that made the iPhone commercially possible.
May 18, 2021
A short argument that genuine creativity requires defying convention — and why that matters for practice.
May 4, 2021
On the ethical concerns that attach to germline CRISPR editing — off-target effects, consent, and the He Jiankui case.
May 4, 2021
How somatic-cell CRISPR therapy — ex vivo, autologous, targeted — could serve health equity rather than widen existing gaps.
May 4, 2021
A focused argument for investment in CRISPR-based therapy for Sickle Cell Disease as an ethical, equitable, and scientifically tractable priority.